Ambrose, Anastasia
Sheehan, Melissa
Bahl, Shalini
Athey, Taryn
Ghai-Jain, Shailly
Chan, Alicia
Mercimek-Andrews, Saadet http://orcid.org/0000-0001-8396-6764
Funding for this research was provided by:
NACTRC
Ultragenyx Pharmaceutical
Article History
Received: 19 May 2022
Accepted: 4 September 2022
First Online: 15 September 2022
Declarations
:
: The Research Ethics Office, Health Research Ethics Board, University of Alberta (Study ID: Pro00108842) approved this retrospective cohort study.All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5).
: Not applicable.
: The authors declare that they have no competing interests.